instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Concomitant disease aggravated'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Recovering | ReactionOutcome | CC BY | 34625019 | 19,971,612 | 2021-10-09 |
What was the outcome of reaction 'Deafness unilateral'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Not recovered | ReactionOutcome | CC BY | 34625019 | 20,087,942 | 2021-10-09 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Recovered | ReactionOutcome | CC BY | 34625019 | 19,972,903 | 2021-10-09 |
What was the outcome of reaction 'Granulomatosis with polyangiitis'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Not recovered | ReactionOutcome | CC BY | 34625019 | 19,970,226 | 2021-10-09 |
What was the outcome of reaction 'Paranasal sinus discomfort'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Not recovered | ReactionOutcome | CC BY | 34625019 | 20,087,942 | 2021-10-09 |
What was the outcome of reaction 'Psoriatic arthropathy'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Recovering | ReactionOutcome | CC BY | 34625019 | 19,971,612 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalitis'. | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | ARTESUNATE, ASCORBIC ACID, ASPARAGINASE, CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA, CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, FOLIC ACID, HYDROCORTISONE, IMATINIB MESYLATE, MERCAPTOPURINE, METHOTREXATE, PREDNISOLONE, PROGUANIL, SULFAMETHOXAZOLE\TRIMETHOPRIM, ... | DrugsGivenReaction | CC BY | 34625105 | 20,078,011 | 2021-10-08 |
What was the administration route of drug 'ASPARAGINASE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Subcutaneous | DrugAdministrationRoute | CC BY | 34625105 | 20,077,939 | 2021-10-08 |
What was the administration route of drug 'CLOTRIMAZOLE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Topical | DrugAdministrationRoute | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the administration route of drug 'DAUNORUBICIN'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34625105 | 20,077,939 | 2021-10-08 |
What was the administration route of drug 'HYDROCORTISONE SODIUM SUCCINATE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intrathecal | DrugAdministrationRoute | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the administration route of drug 'HYDROCORTISONE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intrathecal | DrugAdministrationRoute | CC BY | 34625105 | 20,077,939 | 2021-10-08 |
What was the administration route of drug 'MERCAPTOPURINE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Oral | DrugAdministrationRoute | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the administration route of drug 'METHOTREXATE SODIUM'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intrathecal | DrugAdministrationRoute | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the administration route of drug 'PREDNISOLONE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Oral | DrugAdministrationRoute | CC BY | 34625105 | 20,077,939 | 2021-10-08 |
What was the administration route of drug 'VINCRISTINE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34625105 | 20,077,939 | 2021-10-08 |
What was the dosage of drug 'CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | UNK, PER DAY | DrugDosageText | CC BY | 34625105 | 20,078,011 | 2021-10-08 |
What was the dosage of drug 'HYDROCORTISONE SODIUM SUCCINATE'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | 20 MG; IT DAY 8, 15, 22, 29 | DrugDosageText | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | 12 MG; IT DAY 8, 15, 22, 29 | DrugDosageText | CC BY | 34625105 | 20,091,009 | 2021-10-08 |
What was the outcome of reaction 'Encephalitis'? | Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
BACKGROUND
The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. H... | Fatal | ReactionOutcome | CC BY | 34625105 | 20,078,011 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Clonazepam for pain due to muscle spasm in a patient with vertebral compression fractures caused by multiple myeloma: a case report.
BACKGROUND
Vertebral compression fractures can cause severe back pain. Although many types of analgesics and interventional treatments are available, they are sometimes ineffective in mit... | ACETAMINOPHEN, CLONAZEPAM, FENTANYL, KETAMINE, LIDOCAINE | DrugsGivenReaction | CC BY | 34626259 | 20,624,916 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Clonazepam for pain due to muscle spasm in a patient with vertebral compression fractures caused by multiple myeloma: a case report.
BACKGROUND
Vertebral compression fractures can cause severe back pain. Although many types of analgesics and interventional treatments are available, they are sometimes ineffective in mit... | ACETAMINOPHEN, CLONAZEPAM, FENTANYL, KETAMINE, LIDOCAINE | DrugsGivenReaction | CC BY | 34626259 | 20,624,916 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoptysis'. | Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis.
Pleuroparenchymal fibroelastosis (PPFE) has a variable disease course with dismal prognosis in the majority of patients with no validated drug therapy. This study is to evaluate the effect of nintedanib in patients with idiopathic and secondary PP... | NINTEDANIB | DrugsGivenReaction | CC BY | 34627338 | 19,981,576 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis.
Pleuroparenchymal fibroelastosis (PPFE) has a variable disease course with dismal prognosis in the majority of patients with no validated drug therapy. This study is to evaluate the effect of nintedanib in patients with idiopathic and secondary PP... | NINTEDANIB | DrugsGivenReaction | CC BY | 34627338 | 19,981,576 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis.
Pleuroparenchymal fibroelastosis (PPFE) has a variable disease course with dismal prognosis in the majority of patients with no validated drug therapy. This study is to evaluate the effect of nintedanib in patients with idiopathic and secondary PP... | NINTEDANIB | DrugsGivenReaction | CC BY | 34627338 | 19,981,576 | 2021-10-09 |
What was the dosage of drug 'NINTEDANIB'? | Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis.
Pleuroparenchymal fibroelastosis (PPFE) has a variable disease course with dismal prognosis in the majority of patients with no validated drug therapy. This study is to evaluate the effect of nintedanib in patients with idiopathic and secondary PP... | 150 mg (milligrams). | DrugDosage | CC BY | 34627338 | 19,981,576 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Isotretinoin-associated exercise-induced anaphylaxis in a patient with birch pollinosis and soybean sensitization: case presentation and literature review.
BACKGROUND
Peanut and soybean allergies are listed as contraindication in the package leaflet of isotretinoin, a widely used treatment of acne vulgaris. Cross-react... | ISOTRETINOIN | DrugsGivenReaction | CC BY | 34627369 | 20,703,017 | 2021-10-09 |
What was the administration route of drug 'ISOTRETINOIN'? | Isotretinoin-associated exercise-induced anaphylaxis in a patient with birch pollinosis and soybean sensitization: case presentation and literature review.
BACKGROUND
Peanut and soybean allergies are listed as contraindication in the package leaflet of isotretinoin, a widely used treatment of acne vulgaris. Cross-react... | Oral | DrugAdministrationRoute | CC BY | 34627369 | 20,703,017 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Dual chamber pacemaker implantation in woman with twin pregnancy and Chagas cardiomyopathy guided by 2D transthoracic echocardiography.
We present a case of 36-year-old woman with twin pregnancy, Chagas cardiomyopathy and history of multiple episodes of dizziness and syncope. The patient's Holter study revealed sinus p... | METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY | 34628037 | 20,190,447 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
BACKGROUND Immune thrombocytopenic purpura (ITP) is primarily caused by antibody-mediated destruction of platelets. Alterations in immune homeostasis can induce loss of peripheral tolerance and promote the development of sel... | AZATHIOPRINE | DrugsGivenReaction | CC BY-NC-ND | 34628462 | 20,354,419 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
BACKGROUND Immune thrombocytopenic purpura (ITP) is primarily caused by antibody-mediated destruction of platelets. Alterations in immune homeostasis can induce loss of peripheral tolerance and promote the development of sel... | AZATHIOPRINE, ELTROMBOPAG, FOSTAMATINIB, PREDNISONE, RIFAMPIN, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34628462 | 20,315,945 | 2021-10-10 |
What was the dosage of drug 'FOSTAMATINIB'? | Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
BACKGROUND Immune thrombocytopenic purpura (ITP) is primarily caused by antibody-mediated destruction of platelets. Alterations in immune homeostasis can induce loss of peripheral tolerance and promote the development of sel... | 100 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34628462 | 20,315,945 | 2021-10-10 |
What was the outcome of reaction 'Drug ineffective'? | Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
BACKGROUND Immune thrombocytopenic purpura (ITP) is primarily caused by antibody-mediated destruction of platelets. Alterations in immune homeostasis can induce loss of peripheral tolerance and promote the development of sel... | Recovering | ReactionOutcome | CC BY-NC-ND | 34628462 | 20,354,419 | 2021-10-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subdural haemorrhage'. | Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients.
Haematopoietic stem cell transplantation (HSCT) is used worldwide in various malignant and nonmalignant childhood diseases, including haematologic, genetic, autoimmun... | CYCLOSPORINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34629063 | 20,946,725 | 2021-10-11 |
What was the administration route of drug 'CISPLATIN'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | Other | DrugAdministrationRoute | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the administration route of drug 'ENFORTUMAB VEDOTIN'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | Other | DrugAdministrationRoute | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | Oral | DrugAdministrationRoute | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | Oral | DrugAdministrationRoute | CC BY-NC | 34629907 | 20,688,197 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | UNK, (INFUSION) | DrugDosageText | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | UNK, SYSTEMIC | DrugDosageText | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the dosage of drug 'ENFORTUMAB VEDOTIN'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | UNK,INFUSION | DrugDosageText | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | UNK (LOW DOSE) | DrugDosageText | CC BY-NC | 34629907 | 20,923,377 | 2021 |
What was the outcome of reaction 'Cataract subcapsular'? | Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin.
Enfortumab vedotin is an antibody-drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials ide... | Recovered | ReactionOutcome | CC BY-NC | 34629907 | 20,923,377 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase.
We describe in vivo evolution of carbapenem and ceftazidime-avibactam resistance by analyzing four longitudinal Klebsiella pneumoniae clinical isolates from a pat... | AMIKACIN, AVIBACTAM SODIUM\CEFTAZIDIME, CILASTATIN SODIUM\IMIPENEM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34630354 | 20,353,880 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder. HLH can be considered as a threshold disease depending on the trigge... | PREDNISONE, VINBLASTINE | DrugsGivenReaction | CC BY | 34630398 | 20,477,355 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute coronary syndrome'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,057,978 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,057,978 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contraindicated product prescribed'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,031,307 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,057,978 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | ASPIRIN, ATORVASTATIN, CEPHALEXIN, CLINDAMYCIN, CLOPIDOGREL BISULFATE, ENOXAPARIN, FLUCLOXACILLIN, LOSARTAN, METOPROLOL, NITROGLYCERIN, PREDNISOLONE | DrugsGivenReaction | CC BY | 34630571 | 20,082,398 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,057,978 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Medication error'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,099,920 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product prescribing error'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,056,394 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,013,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urticaria'. | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | CEPHALEXIN, CLINDAMYCIN, FLUCLOXACILLIN | DrugsGivenReaction | CC BY | 34630571 | 20,013,359 | 2021 |
What was the administration route of drug 'CLINDAMYCIN'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34630571 | 20,056,394 | 2021 |
What was the administration route of drug 'ENOXAPARIN'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Subcutaneous | DrugAdministrationRoute | CC BY | 34630571 | 20,082,398 | 2021 |
What was the administration route of drug 'FLUCLOXACILLIN'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34630571 | 20,056,394 | 2021 |
What was the administration route of drug 'NITROGLYCERIN'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Sublingual | DrugAdministrationRoute | CC BY | 34630571 | 20,082,398 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | 10 mg (milligrams). | DrugDosage | CC BY | 34630571 | 20,082,398 | 2021 |
What was the outcome of reaction 'Acute coronary syndrome'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,057,978 | 2021 |
What was the outcome of reaction 'Acute myocardial infarction'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,057,978 | 2021 |
What was the outcome of reaction 'Drug hypersensitivity'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,057,978 | 2021 |
What was the outcome of reaction 'Hypersensitivity'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,031,307 | 2021 |
What was the outcome of reaction 'Kounis syndrome'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,056,394 | 2021 |
What was the outcome of reaction 'Left ventricular dysfunction'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,057,978 | 2021 |
What was the outcome of reaction 'Medication error'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,099,920 | 2021 |
What was the outcome of reaction 'Pruritus'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,013,359 | 2021 |
What was the outcome of reaction 'Urticaria'? | Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.
Kounis syndrome is the concurrence of an acute coronary syndrome (ACS) caused by coronary vasospasms, acute myocardial infarctions, or stent thromboses in case of allergic or hypersensitivity reactions. Kounis syndrome is mediated by mast cells that intera... | Recovered | ReactionOutcome | CC BY | 34630571 | 20,013,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,522 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Body mass index decreased'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,002,046 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal distress syndrome'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,002,046 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gestational hypertension'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal deformity'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,002,046 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placenta praevia'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,002,046 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy.
To explore the clinical effects of sodium valproate and levetiracetam in the treatment of women with epilepsy during pregnancy.
The clinical data of 124 women with epilepsy during pregnancy w... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34630611 | 20,004,967 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Multiple superficial femoral artery pseudoanurysms following sub intimal application of paclitaxel coated technology.
Drug coated balloons (DCB) are a commonly used endovascular option for treating patients presenting with symptomatic peripheral vascular disease. DCB have illustrated to increase primary patency and thu... | PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34630788 | 20,437,526 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pseudoaneurysm'. | Multiple superficial femoral artery pseudoanurysms following sub intimal application of paclitaxel coated technology.
Drug coated balloons (DCB) are a commonly used endovascular option for treating patients presenting with symptomatic peripheral vascular disease. DCB have illustrated to increase primary patency and thu... | PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34630788 | 20,437,526 | 2021-12 |
What was the administration route of drug 'PACLITAXEL'? | Multiple superficial femoral artery pseudoanurysms following sub intimal application of paclitaxel coated technology.
Drug coated balloons (DCB) are a commonly used endovascular option for treating patients presenting with symptomatic peripheral vascular disease. DCB have illustrated to increase primary patency and thu... | Intra-arterial | DrugAdministrationRoute | CC BY-NC-ND | 34630788 | 20,437,526 | 2021-12 |
What was the dosage of drug 'PACLITAXEL'? | Multiple superficial femoral artery pseudoanurysms following sub intimal application of paclitaxel coated technology.
Drug coated balloons (DCB) are a commonly used endovascular option for treating patients presenting with symptomatic peripheral vascular disease. DCB have illustrated to increase primary patency and thu... | PACLITAXEL COATED BALLOON ANGIOPLASTY | DrugDosageText | CC BY-NC-ND | 34630788 | 20,437,526 | 2021-12 |
What was the outcome of reaction 'Vascular pseudoaneurysm'? | Multiple superficial femoral artery pseudoanurysms following sub intimal application of paclitaxel coated technology.
Drug coated balloons (DCB) are a commonly used endovascular option for treating patients presenting with symptomatic peripheral vascular disease. DCB have illustrated to increase primary patency and thu... | Recovered | ReactionOutcome | CC BY-NC-ND | 34630788 | 20,437,526 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 34630794 | 20,505,277 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | AZITHROMYCIN, CEFTRIAXONE, DEXAMETHASONE, HEPARIN SODIUM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34630794 | 20,576,300 | 2021-12 |
What was the administration route of drug 'AZITHROMYCIN'? | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34630794 | 20,483,242 | 2021-12 |
What was the administration route of drug 'CEFTRIAXONE'? | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34630794 | 20,505,277 | 2021-12 |
What was the administration route of drug 'PREDNISOLONE'? | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34630794 | 20,576,300 | 2021-12 |
What was the administration route of drug 'PREDNISONE'? | Spontaneous pneumomediastinum: A collaborative sequelae between COVID-19 and self-inflicted lung injury - A case report and literature review.
Spontaneous pneumomediastinum is an infrequent complication of COVID-19. The mechanism is still unknown and thought to be related to patient self-inflicted lung injury. Our pati... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34630794 | 20,483,242 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amenorrhoea'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,004,985 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device issue'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,004,985 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,381,796 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ectopic pregnancy with contraceptive device'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,381,796 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,006,875 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoperitoneum'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,004,985 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ruptured ectopic pregnancy'. | A ruptured ectopic pregnancy in a patient with an intrauterine device: A case report.
Intrauterine devices (IUDs) are used worldwide. The 2 types that are used are the levonorgestrel IUD and a copper containing IUD. This is a case study of a 30-year-old female with a levonorgestrel IUD who was diagnosed with a ruptured... | LEVONORGESTREL | DrugsGivenReaction | CC BY-NC-ND | 34630798 | 20,381,796 | 2021-12 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.